Merck awards miniaturised NMR spectroscopy concept

Merck Pty Ltd

Friday, 19 April, 2019


Merck awards miniaturised NMR spectroscopy concept

Science and technology company Merck last month announced the winner of its Next Game-Changing Technology prize, created as part of the company’s 350 Research Challenges initiative. Dr Liam Hall, of the University of Melbourne, won for his concept ‘Time-dependent in situ NMR spectroscopy, based on Nitrogen-Vacancy Defects in Diamonds’.

Merck’s Innovation Center, located at the company’s headquarters in Germany, awards the Next Game-Changing Technology prize to technologies with the potential to disrupt and fundamentally change the healthcare, life science or performance materials markets. The challenge was initiated by Merck’s Innovation and Entrepreneurship Incubator, organised within the context of the company’s 350th anniversary celebrations.

Dr Hall’s concept addresses the challenge of in situ monitoring of chemical composition in microscopic reaction systems on timescales previously inaccessible to nuclear magnetic resonance techniques. Time-dependent monitoring of NMR signatures associated with short-lived intermediate species will provide a new window into the relevant processes of reaction mixtures and nano-assembly systems. This research has the potential to revolutionise our understanding of many chemical reaction mechanisms and pathways, and thus promises to catalyse further research in synthetic chemistry and biochemical fields.

Dr Hall’s concept convinced the judges because of the way it complements projects already running within Merck’s Innovation Center, and the future relevance of the field for Merck. While Merck employees at the Innovation Center are already working on a solution for X-ray crystallography without the need for crystallisation, Dr Hall’s work concentrates on NMR using diamond-based detector devices, which is aimed at enabling the investigation of individual cells.

“Dr Liam Hall has shown a series of developments in NMR, a workhorse in chemical structural analytics as well as non-invasive medical imaging techniques, which are leading to enhanced sensitivity and miniaturisation of this key technology,” said prize sponsor Christoph Huels, Head of Technology Foresight & Scouting at Merck’s Innovation Center. “We consider this concept as a breakthrough in the well-established NMR spectroscopy technique and congratulate him on his success.”

Image credit: ©stock.adobe.com/au/vege

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Abcam purchases assets from Applied StemCell

Abcam has announced the asset purchase of the gene editing platform and oncology product...

Aussie astronomer Lisa Kewley wins James Craig Watson Medal

Professor Lisa Kewley has been awarded the 2020 James Craig Watson Medal by the US National...

Blood-clotting treatment wins Drug Discovery of the Year 2020

Caplacizumab is said to be the first nanobody therapy to treat adults with the rare autoimmune...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd